https://www.aoncology.com/wp-content/uploads/2023/02/Biosimilars-Blog-02232023.jpg
824
1200
Caroline Hewitt
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg
Caroline Hewitt2023-02-27 07:00:002023-02-27 08:04:28Biosimilar Adoption Within the Oncology Industry
https://www.aoncology.com/wp-content/uploads/2023/02/Cancer-in-African-Americans-Blog.jpg
800
1200
Caroline Hewitt
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg
Caroline Hewitt2023-02-22 07:00:002025-02-08 19:36:10Three Facts About Cancer in African American Communities
https://www.aoncology.com/wp-content/uploads/2023/02/Multiple-Myeloma-Article.jpg
800
1616
Caroline Hewitt
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg
Caroline Hewitt2023-02-21 12:02:342023-02-21 14:21:50In Community-Based Study, Switching to Ixazomib in Newly Diagnosed MM Brought Improved Responses Across Age Groups
https://www.aoncology.com/wp-content/uploads/2023/02/AON_Pharmacy_Inside_15-blog.jpg
798
1282
Caroline Hewitt
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg
Caroline Hewitt2023-02-14 15:55:182023-02-14 16:36:01What Does the URAC Re-Accreditation Mean for You?
https://www.aoncology.com/wp-content/uploads/2022/11/Breast-Cancer-Blog-11072022.jpg
801
1200
Caroline Hewitt
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg
Caroline Hewitt2022-11-07 13:13:132022-11-07 13:26:16Diagnosed With Breast Cancer? Ask These Eight Questions
https://www.aoncology.com/wp-content/uploads/2022/09/Natural-Hazard-Blog-e1664387934469.jpg
570
1200
Caroline Hewitt
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg
Caroline Hewitt2022-09-28 13:51:152022-09-29 08:37:54Natural Hazard Preparedness: Your To-Do List as a Cancer Patient
